Latent membrane protein (LMP) is a latent EpsteinBarr virus (EBV) protein expressed in the EBV associated malignancy, nasopharyngeal carcinoma (NPC). Properties ascribed to this protein include inhibition of epithelial cell dierentiation and deregulation of epithelial cellular gene expression, and are believed to contribute to the development of NPC. Studies to evaluate the oncogenic potential of LMP in epithelial cells have not been conclusive. We carried out studies to determine the tumorigenic activity of LMP in two human epithelial cell lines, SCC12F and HaCaT; while SCC12F LMP transfectants were non-tumorigenic in severe combined immunode®cient mice, HaCaT LMP transfectants were strongly oncogenic. The tumours produced were well dierentiated, keratinising squamous cell carcinomas suggesting that LMP does not inhibit epithelial cell dierentiation which con¯icts with a previous report by Dawson et al. (1990) . To resolve this discrepancy we examined the ability of HaCaT and SCC12F LMP transfectants to dierentiate in a suspension culture assay. Both lines were able to dierentiate to a similar extent as parental lines and control transfectants. Our results indicate that LMP is strongly oncogenic in human epithelial cells but that inhibition of dierentiation is not necessarily a mechanism by which LMP contributes to the pathogenesis of NPC.
Introduction
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus with approximately 90% of the adult population worldwide being infected (Niederman et al., 1970) . Asymptomatic primary infection usually occurs during early childhood, however, when infection is delayed until adolescence or adulthood EBV can cause infectious mononucleosis (Henle et al., 1968) . Thereafter, EBV persists for the life of the individual (Golden et al., 1973) , and it is this viral persistence that is believed to play a role in the development of a number of human malignancies of lymphoid and epithelial cell origin (Rickinson and Kie, 1996) .
EBV is consistently associated with the epithelial tumour nasopharyngeal carcinoma (NPC). This tumour occurs at low incidence in Europe and the USA, but at much higher incidence in southeast Asia, particularly southern China. Environmental and genetic factors are implicated in the development of NPC, but it is the contribution of EBV that has been the focus of our studies. NPC has been categorised by the World Health Organisation (WHO) into three types according to the degree of epithelial differentiation ± keratinising squamous cell carcinoma (WHO1), non-keratinising carcinoma (WHO2) and undifferentiated carcinoma (WHO3). Examination of biopsy material has shown there to be a consistent association of EBV with all types of NPC (Wolf et al., 1973; Pathmanathan et al., 1995a) . In addition, clonal EBV genomes are found within these tumours indicating the presence of EBV within the transformed cell (RaabTraub and Flynn, 1986) .
EBV gene expression has been studied extensively in NPC biopsies, and genes associated with a latent viral infection are expressed. Transcripts for several EBV genes have been detected and include RNAs of two membrane proteins, terminal protein (TP)1 and 2 (Brooks et al., 1992) . In latently infected B lymphocytes, TP1 expression blocks surface immunoglobulinmediated reactivation of EBV from latency (Miller et al., 1994) , an eect believed to result from the interaction of TP1 with src family tyrosine kinases (Longnecker et al., 1991) . Consistent expression of TP1 in NPC may suggest that it similarly contributes to maintenance of latent infection in these epithelial cells. Two small nuclear EBV-encoded RNAs (EBERs)1 and 2 are transcribed but not translated. A family of cytoplasmic RNAs derived from the BamHI A region of the EBV genome are expressed (Karran et al., 1992) . Until recently, protein products of these RNAs had not been identi®ed, and it was hypothesised that as the RNAs are transcribed in antisense orientation to lytic cycle genes they may be involved in the maintenance of latency. Recent studies, however, indicate that the BamHI A transcripts encode a protein product which may play a role in tumour development (Sculley et al., 1997) . In addition, the viral proteins EBV nuclear antigen (EBNA)1 and latent membrane protein (LMP) are expressed. EBNA1 is consistently expressed in NPC cells, and is a sequence-speci®c DNA binding protein involved in maintenance and replication of the EBV episome within the cell (Yates et al., 1985) . In addition, EBNA1 has been shown to induce expression of the recombinase-activating genes RAG1 and RAG2 in B lymphocytes (Srinivas and Sixbey, 1995), which may be a contributing factor to EBNA1-induced B cell lymphomas in transgenic mice (Wilson et al., 1996) . LMP is detected in approximately two-thirds of tumour biopsies examined (Fahraeus et al., 1988) , and in a recent study of EBV gene expression in preinvasive nasopharyngeal lesions LMP was detected in six of six cases (Pathmanathan et al., 1995b) . The eect of LMP expression on epithelial cells has been the subject of intensive study, and results would indicate that LMP contributes to the development of NPC.
Expression of LMP in the skin of transgenic mice induces a type of epidermal hyperplasia characterised by an increased number of cell layers when compared with normal epidermis, disorganisation of the differentiating layers and aberrant expression of the hyperproliferative keratin, K6 (Wilson et al., 1990) . Although disorganisation of the dierentiating layers was observed, the epidermis was nonetheless able to undergo full dierentiation, as is typical of human epidermal hyperplastic conditions such as psoriasis.
A similar eect was observed when LMP transfectants of the human epithelial cell line, SCC12F were cultured on rafts of collagen at an air-liquid interface (Dawson et al., 1990) . When normal human epidermal keratinocytes are cultured on collagen rafts they stratify and dierentiate to form a structure very similar to that seen in vivo. Collagen raft cultures of SCC12F LMP transfectants were found to be much thicker and less well organised when compared with control cultures, and decreased expression of involucrin, a marker of epithelial cell dierentiation was seen. These results were interpreted as an LMP-induced inhibition of epithelial terminal dierentiation although alternative interpretations such as an eect of LMP on proliferation and/or apoptosis cannot be ruled out.
Expression of LMP in the cervical epithelial cell line, C33A increased expression of the anti-apoptotic gene, A20 and the epidermal growth factor receptor (EGFR; Miller et al., 1995) . The EGFR has been implicated in the deregulation of cellular growth control and is often overexpressed in carcinomas including NPC (Miller et al., 1995) . The increased proliferative signals due to enhanced EGFR expression, as well as protection from cell death by induced A20 expression may provide a mechanism by which LMP contributes to NPC development, and may explain the increased number of cell layers observed following LMP expression in the skin of transgenic mice and in collagen raft cultures of SCC12F cells, although expression of EGFR and A20 were not examined in these systems.
The molecular mechanism by which LMP exerts its varied eects in epithelial cells is not known, however, it has been shown that LMP can activate the transcription factor, nuclear factor kB (NF-kB) in a variety of cell types including epithelial cells (Hammarskjold and Simurda, 1992; Laherty et al., 1992; Paine et al., 1995) . LMP may upregulate A20 via NFkB, as shown in B lymphocytes (Laherty et al., 1992) , however, other eects of LMP such as induced upregulation of EGFR expression do not seem to occur via activation of NF-kB, indicating the involvement of other molecular mechanisms.
LMP is essential for the immortalisation of human B lymphocytes in vitro (Kaye et al., 1993) , and when expressed in established Rat-1 ®broblasts induces the formation of tumours in nude mice (Wang et al., 1985) . The LMP genes of two NPC (NPC CAO, a nude mouse-passaged Chinese NPC and NPC 1510, a NPC of Taiwanese origin) have recently been sequenced and compared with the standard B95-8 derived LMP sequence (Hu et al., 1991; Chen et al., 1992 . More recent data indicate that the 30 bp deletion in the carboxy terminus plays a crucial role in the oncogenic activity of 1510 LMP (Li et al., 1996) . Similarly, nine of 24 human RHEK-1 epithelial clones expressing CAO LMP were tumorigenic in severe combined immunode®cient (SCID) mice, while only one of 12 RHEK-1 clones expressing B95-8 LMP were tumorigenic (Hu et al., 1993) . These studies indicate that NPC derived LMP genes, CAO and 1510, may have greater oncogenic potential than that of B95-8 derived LMP. That one of 12 RHEK-1 clones expressing B95-8 LMP was tumorigenic suggests that tumorigenicity was the result of insertional activation or inactivation of a gene following integration of vector into genomic DNA, however, these results do not conclusively rule out oncogenic activity of B95-8 LMP in human epithelial cells. We therefore carried out studies to determine the tumorigenic activity of human keratinocytes following stable transfection of B95-8 LMP. We show that three out of three HaCaT clones expressing B95-8 LMP were tumorigenic in SCID mice, while no tumours were produced by three transfectants of the SCC12F cell line. These results indicate that LMP is strongly oncogenic in certain cellular backgrounds, and that there is no need to invoke NPC LMP strains. In addition, we show that the tumours produced by HaCaT LMP transfectants were well dierentiated keratinising squamous cell carcinomas. This was a surprising result in view of the reported inhibition of epithelial cell dierentiation by LMP (Dawson et al., 1990) , however, subsequent in vitro analyses have supported our ®nding and shown that LMP does not inhibit dierentiation of HaCaT or SCC12F epithelial cells in suspension culture.
Results

Tumorigenicity
Three LMP transfectants and two control transfectants of the HaCaT and SCC12F epithelial cell lines were injected subcutaneously into the¯anks of SCID mice to test for tumorigenicity (Table 1) . Neither control (Sneo1,2) nor LMP transfectants (SLMP1,2,3) of the SCC12F cell line produced tumours in SCID mice. LMP transfectants of the HaCaT line, however, did produce varying numbers of tumours; HLMP1 induced four of six tumours, HLMP2 induced three of ®ve tumours and HLMP3 induced two of six tumours. All tumours appeared 6 to 8 weeks following inoculation. Control HaCaT transfectants (Hneo1,2) did not produce tumours in SCID mice.
LMP expression
To con®rm LMP expression in the HaCaT and SCC12F clones, lines were analysed by immunoblotting using supernatant containing the anti-LMP antibody, S12. HaCaT and SCC12F LMP transfectants expressed a 63 kDa LMP molecule corresponding in size to the LMP band of the EBV-transformed B lymphocyte line, B95-8 ( Figure 1 ). LMP expression in the SCC12F LMP transfectants varied, with SLMP2 expressing the highest levels, SLMP3 the lowest and SLMP1 intermediate levels. All three transfectants expressed lower levels of LMP than B95-8. LMP expression in the HaCaT LMP transfectants was also variable with HLMP2 expressing the highest levels and HLMP1 and three expressing similar, lower levels. The three HaCaT LMP transfectants expressed considerably lower levels of LMP than B95-8, and lower levels than the three SCC12F LMP transfectants. Additional, lower molecular weight bands seen in the SLMP2 track are probably degradation products, and those seen in the B95-8 tracks are probably degradation products and/or lytic cycle LMP. Untransfected parental lines and control lines transfected with pSV2-neo alone did not express LMP.
Characterisation of tumours
All tumours were non-invasive, and metastases were not evident in the organs histologically examined, namely the lungs, liver and spleen (data not shown). The tumours were characterised immunohistochemically, and representative results are shown in Figure 2 . Involucrin is the major protein precursor of the corni®ed envelope, a structure formed in the cornified cells of human keratinising squamous epithelia. In normal skin, involucrin is expressed in the upper spinous, granular and coni®ed layers, and serves as a marker of epithelial cell dierentiation. Figure 2a shows a tumour section stained for involucrin using the rabbit polyclonal antibody, DH1; all cells bar those in the basal and lower suprabasal layers were positively stained for involucrin, indicating a well dierentiated keratinising squamous cell carcinoma. As involucrin is not expressed in mouse epithelial cells, the stained section con®rms the human origin of the tumour cells.
Epithelial cells characteristically express a class of intermediate ®laments termed cytokeratins, and as such can be used as an epithelial cell marker. Figure 2b is a tumour section stained for cytokeratins using the mouse monoclonal antibody, LP34. Positive staining was seen in the cytoplasm of all cells of the tumour, verifying the epithelial nature of the tumour. Again, the stained section indicates a well dierentiated keratinising squamous cell carcinoma with prominent keratin pearls.
Ki-67 recognises a nuclear antigen present in cycling cells and absent from quiescent cells, and is widely used to assess cell proliferation in clinical material. In normal keratinising squamous epithelia such as the skin, Ki-67 expression is con®ned to the basal layers. A similar pattern of staining was observed when tumour sections were stained with a rabbit polyclonal antibody to Ki-67, that is, positively stained cells were observed in the basal and lower suprabasal layers of the stratifying tumour epithelium (Figure 2c ).
To ensure that the HaCaT LMP transfectants continued to express LMP following subcutaneous injection into SCID mice, tumour sections were stained for LMP using a cocktail of mouse monoclonal antibodies, CS1-4. As can be seen in Figure 2d , membrane associated and cytoplasmic LMP was expressed by all cells of the tumour. LMP staining was, however, more intense in the more dierentiated tumour cells, which may be due to dierentiationdependent regulation of the SV40 promoter driving expression of the LMP gene in epithelial cells or possibly to changes in LMP half-life, RNA stability with epithelial cell dierentiation. 
Contribution of cellular genes to tumorigenicity
LMP transfectants of the HaCaT cell line produced tumours in SCID mice while SCC12F LMP transfectants did not, indicating the contribution of cellular factor(s) to tumour development. Mutation and/or overexpression of the p53 tumour suppressor gene is a frequent event in many types of human cancer (Hollstein et al., 1991) including NPC (Niedobitek et al., 1993) . Mutation resulting in overexpression of the HaCaT p53 gene has been reported (Lehman et al., 1993) , and raises the possibility that this property of the HaCaT cell line is required to allow expression of LMP oncogenicity. To con®rm p53 overexpression in SCID mouse tumours, sections were stained for p53 using the rabbit polyclonal antibody, CM1. Figure 2e shows nuclear p53 expression in cells of the basal and lower suprabasal layers of stratifying epithelium. Expression of p53 was dependent upon the differentiation status of the epithelial cells, with positive staining con®ned to the less dierentiated basal and lower suprabasal layers, that is, layers which contain the proliferative Ki-67 positive cells. The bcl-2 oncogene is a negative regulator of apoptosis and has been implicated in the pathogenesis of various cancers including NPC in which overexpression of bcl-2 has been observed in tissue biopsies (Lu et al., 1993) . Figure 2f shows a tumour section stained for bcl-2 with mouse monoclonal antibody 124. All tumours were found to be negative for bcl-2 indicating that bcl-2 does not play a role in the development of these tumours.
Epithelial cell dierentiation in vitro
Our results show that LMP transfectants of the HaCaT epithelial cell line form well dierentiated keratinising squamous cell carcinomas when injected subcutaneously into SCID mice, indicating that epithelial cell dierentiation was not inhibited by LMP. This ®nding con¯icts with a report by Dawson et al. (1990) who studied the eects of stable LMP expression on SCC12F epithelial cells in vitro. In their study, SCC12F LMP transfectants cultured on collagen rafts formed much thicker, less well organised structures with decreased involucrin expression when compared with control cultures, and the results were interpreted as an inhibition of epithelial cell dierentiation. To investigate the possible eect of LMP upon differentiation of epithelial cells further and resolve the discrepancy between our in vivo results and the in vitro results of Dawson et al. (1990) , we carried out experiments to determine the capacity of HaCaT and SCC12F LMP transfectants to undergo terminal dierentiation in suspension culture.
When normal human keratinocytes are suspended in culture medium made viscous by the addition of methylcellulose, the cells are prevented from having contact with each other or with the substratum and undergo a programme of almost synchronous terminal differentiation (Green, 1977; Nicholson and Watt, 1991) . Similarly, epithelial cell lines such as SCC12F are also induced to undergo terminal dierentiation following culture in suspension (Karimi et al., 1995) . This culture system provides a direct method of assessing the dierentiation potential of epithelial cells in vitro.
We placed parental cells, pSV2-neo transfectants and LMP transfectants of the SCC12F and HaCaT lines in suspension culture for 72 h, and assessed involucrin expression before and after culture (Table 2; involucrin expression is a good marker of epithelial cell differentiation as, in culture, all dierentiating human keratinocytes express involucrin). When parental SCC12F cells were placed in suspension culture for 72 h there was a 7.8-fold increase in the number of cells expressing involucrin. Similarly, when pSV2-neo transfectants were cultured in suspension, there were 13.5 (Sneo1) and 7.5 (Sneo2)-fold increases in involucrin expression. When LMP transfectants were cultured in suspension, there were 8.3 (SLMP1), 8.8 (SLMP2) and 10.3 (SLMP3)-fold increases in involucrin expression. Statistical analysis showed that there was no signi®cant dierence between the fold increases in involucrin expression observed following suspension culture of control lines (SCC12F parental cells and SCC12F cells transfected with pSV2-neo) and those observed following suspension culture of SCC12F cells expressing LMP. A similar set of results was observed when HaCaT parental, pSV2-neo and LMP HaCaT transfectants were placed in suspension culture, that is, control lines as well as LMP expressing lines were able to undergo terminal dierentiation, and to a similar extent (Table 2) . Although there was no signi®cant dierence between the fold increases in involucrin expression observed following suspension culture of control HaCaT lines and LMP HaCaT transfectants, pSV2-neo clones tended to undergo a lower fold increase in the number of involucrin positive cells following suspension culture; the reason for this is unclear.
To con®rm that SCC12F and HaCaT LMP transfectants continued to express LMP following 72 h culture in suspension, cells were analysed for LMP expression by immunoblotting both before and after suspension culture. All LMP transfectants expressed LMP before and after culture in suspension, and representative results with the SCC12F clones are shown in Figure 3 . Higher levels of LMP expression were observed following 72 h in suspension culture when compared with levels expressed at 0 h, again indicating epithelial dierentiation dependent regulation of the SV40 promoter controlling LMP gene expression and/or changes in LMP half-life, RNA stability.
These in vitro results con®rm the ®ndings of our in vivo studies indicating no detectable eect of LMP on the ability of human epithelial cells to dierentiate.
Discussion
Our studies are the ®rst to demonstrate strong oncogenic activity of B95-8 derived LMP in human epithelial cells. Previously CAO LMP (LMP derived from a nude mouse-passaged Chinese NPC) was shown to have oncogenic activity in the human epithelial cell line, RHEK-1, while B95-8 LMP was shown to have weak or no oncogenicity in RHEK-1 cells (Hu et al., 1993) . We determined the tumorigenicity of B95-8 LMP transfectants of two human epithelial cell lines, HaCaT and SCC12F; we found that three out of three HaCaT LMP transfectants were tumorigenic in SCID mice while no tumours were produced by the three SCC12F LMP transfectants, which expressed higher levels of LMP than the HaCaT LMP transfectants. These results show that B95-8 LMP has oncogenic activity in human epithelial cells, but that demonstrable oncogenic potential is dependent upon the genetic background of the transfected host cell. Our results also show that nucleotide changes of the B95-8 LMP molecule to the NPC LMP form are not necessary for oncogenic activity. In view of these ®ndings it would be interesting to compare oncogenicity of B95-8 LMP with CAO LMP in SCC12F cells.
The tumours produced by the HaCaT LMP transfectants were well dierentiated keratinising squamous cell carcinomas, a ®nding which compliments that of Pathmanathan et al. (1995a) who detected LMP expression in well dierentiated squamous cell NPC biopsies. These results do, however, con¯ict with the reported ability of LMP to inhibit epithelial cell dierentiation in vitro (Dawson et al., 1990) . We therefore assessed the ability of HaCaT and SCC12F LMP transfectants to undergo terminal dierentiation in vitro using a suspension culture assay. Results showed that LMP transfectants were able to undergo dierentiation to a similar extent as control lines, indicating no detectable eect of LMP on epithelial cell dierentiation. This conclusion is supported by our in vivo data, by the ®nding that LMP is expressed in samples of well dierentiated squamous cell NPC (Pathmanathan et al., 1995a) and by the studies of Wilson et al. (1990) who showed that LMP induces epidermal hyperplasia when expressed in the skin of transgenic mice and does not inhibit epidermal dierentiation. In the study of Dawson et al. (1990) it was concluded that LMP inhibits epithelial cell dierentiation in vitro, a conclusion that is not substantiated by the in vivo and in vitro experimental systems described above.
Experiments carried out by Dawson et al. (1990) involved the culture of SCC12F LMP transfectants on rafts of collagen at an air-liquid interface. Under these conditions human epidermal keratinocytes form a stratifying, well dierentiated structure similar histologically to human epidermis. Collagen raft cultures of SCC12F LMP transfectants formed much thicker, less organised structures with decreased involucrin expression when compared with control cultures. This eect of LMP expression on the morphology of SCC12F collagen raft cultures was very similar to that observed following expression of LMP in the epidermis of transgenic mice, in which LMP induced a type of hyperplasia characterised by an increased number of epithelial cell layers, disorganisation of the epidermis and aberrant expression of the hyperproliferative keratin, K6 (Wilson et al., 1990) . One could speculate that the results reported by Dawson et al. (1990) indicate an LMP-induced epithelial hyperplasia possibly brought about by a change in the proliferative and/ or apoptotic pathways as suggested by the studies of Miller et al. (1995) , in which LMP was shown to increase expression of the epidermal growth factor receptor and the anti-apoptotic gene A20 in epithelial C33A cells. Alternatively, a contradiction between the conclusions of the present study and those of Dawson et al. (1990) may be explained by the fact that dierent in vitro assays were used, emphasising the need to use a variety of in vivo and in vitro experimental systems to assess the various eects of LMP on epithelial cells. Another explanation may be that the SCC12F LMP transfectants used in the two studies expressed LMP at dierent levels, thereby modulating the eect of LMP expression on epithelial cell dierentiation. For example, it has been demonstrated that high level expression of the LMP gene in RHEK-1 epithelial cells induces apoptosis and does not aect growth in soft agarose (Lu et al., 1996) , while low level LMP expression in the same cells induces clonability in soft agarose and LMPinduced apoptosis was not observed (Hu et al., 1993) . (SLMP1,2,3) , SCC12F control transfectants (Sneo1,2), HaCaT, HaCaT LMP transfectants (HLMP1,2,3) and HaCaT control transfectants (Hneo1,2) were induced to undergo terminal dierentiation in suspension culture. The dierences in tumorigenicity following expression of LMP in dierent epithelial cell lines can be exploited to provide a model system with which to characterise the molecular mechanisms of LMP action in tumours of epithelial cell origin. This model system can also be used to evaluate the contribution of host cell genetic factors, such as tumour suppressor genes and activated cellular oncogenes, to the formation of tumours in SCID mice. We analysed expression of the p53 tumour suppressor gene and the anti-apoptotic bcl-2 gene in tumours produced by HaCaT LMP transfectants as overexpression of both genes has been implicated in the pathogenesis of NPC (Niedobitek et al., 1993; Lu et al., 1993) . Tumour sections were negative for bcl-2, indicating that bcl-2 does not play a role in tumour development. Studies examining bcl-2 expression in NPC have found expression in undifferentiated and non-keratinising NPC biopsies but much less frequently in keratinising NPC samples (Lu et al., 1993; Kouvidou et al., 1995) . Data from these studies also showed that there was no correlation between expression of bcl-2 and LMP, indicating that LMP does not modulate bcl-2 expression in NPC. In addition, we and others have found that LMP does not induce bcl-2 expression in human epithelial cells (Nicholson and Packham, unpublished data; Lu et al., 1996) . The data presented here would con®rm these previous ®ndings.
Overexpression of p53 was observed in the SCID mouse tumours, raising the possibility that p53 expression may be required for expression of LMP oncogenicity. Mutation and overexpression of the p53 gene in the HaCaT cell line has been reported (Lehman et al., 1993) , and presumably accounts for the p53 expression observed in the SCID mouse tumours. An eect of LMP expression on p53 levels, however, cannot be ruled out, as it has been shown that LMP can induce p53 expression in resting human B cells (Chen and Cooper, 1996) . The p53 status of the SCC12F cell line is not known, and the gene is currently being sequenced. Interestingly, p53 overexpression in the SCID mouse tumours was linked to the dierentiation status of the epithelial cells, indicating that expression of mutated p53 is subject to a certain degree of regulation.
In conclusion, we have demonstrated that B95-8 derived LMP is oncogenic in human epithelial cells when injected subcutaneously into SCID mice. In addition, we show that LMP does not inhibit epithelial cell dierentiation in the in vivo and in vitro systems employed in this study, and that LMP possibly contributes to epithelial tumour development by aecting proliferation and/or apoptotic pathways.
Materials and methods
Cell culture
SCC12F is an immortalised, non-tumorigenic human epithelial cell line established from a squamous cell carcinoma of the facial epidermis (Rheinwald and Beckett, 1980) . HaCaT is a spontaneously immortalised, non-tumorigenic human epithelial cell line derived from adult skin grown in low calcium and at elevated temperature (Boukamp et al., 1988) . HaCaT cells were cultured in RPMI 1640 medium (Life Technologies Ltd, Paisley, UK) plus 10% foetal calf serum (FCS; Sera-Lab Ltd, Crawley Down, UK). SCC12F cells were grown in the presence of a feeder layer of 3T3 cells (clone J2) pretreated with 4 mg/ml mitomycin C (Sigma Chemical Co, Poole, UK) for 2 h (Rheinwald and Green, 1975; Rheinwald, 1980) . The culture medium consisted of three parts Dulbecco's modi®ed Eagle's medium plus one part Ham's F12 (Life Technologies Ltd), supplemented with 1.8610 74 M adenine (Sigma Chemical Co), 5 mg/ml insulin (Sigma Chemical Co), 0.5 mg/ml hydrocortisone (Calbiochem-Novabiochem (UK) Ltd, Nottingham, UK) and 10% FCS. SCC12F cells were seeded at 10 5 cells per 10 cm Petri dish (Corning, Griths and Nielsen Ltd, Billingshurst, UK). B95-8, an EBV genome-positive marmoset cell line (Miller et al., 1972) , was cultured in RPMI 1640 medium containing 10% heat-inactivated FCS. Cultures were incubated at 378C in a fully humidi®ed, 5% CO 2 atmosphere, and medium was changed twice weekly.
Plasmids and stable transfection
Plasmid pJ132 encodes B95-8 derived LMP under transcriptional control of the early promoter of simian virus 40 (SV40), and was the generous gift of Dr Rymo, Gothenburg University (Fahraeus et al., 1990) . The plasmid pSV2-neo encodes the gene conferring neomycin resistance under control of the SV40 early promoter (Southern and Berg, 1982) . HaCaT and SCC12F cells were co-transfected with 1 mg pSV2-neo plus 10 mg pJ132 per 10 cm Petri dish using Lipofectin Reagent (Life Technologies Ltd) according to manufacturer's instructions. PSV2-neo was also transfected alone as a control. Cells were incubated overnight with the Lipofectin Reagent/DNA mixture, washed twice with medium and incubated for a further 48 h in culture medium. The cells were then subjected to drug selection in culture medium containing Geneticin (Life Technologies Ltd) at 500 mg/ml for HaCaT cells and 400 mg/ml for SCC12F cells. Single colonies were ring cloned and expanded to stable lines in selection medium. Antibodies S12 is a mouse monoclonal antibody raised against the carboxyl portion of LMP (Mann et al., 1985) , and CS1-4 is a cocktail of four mouse monoclonal antibodies that recognise distinct epitopes on the carboxyl region of LMP (Rowe et al., 1987) . LP34 is a mouse anti-human monoclonal antibody reactive with cytokeratins 5, 6 and 18 (Lane et al., 1985) . Rabbit anti-human polyclonal antibody, Ki-67 labels proliferating cells, and reacts with cells at all stages of the cell cycle but not with cells in G 0 (Keg et al., 1993) . CM1 is a rabbit anti-human polyclonal antibody that recognises wild type and mutant forms of p53 (Midgley et al., 1992) , and mouse anti-human monoclonal antibody 124 reacts with the bcl-2 oncoprotein (Pezzella et al., 1990) . CS1-4, LP34, Ki-67 and 124 were supplied by Dako Ltd (High Wycombe, UK), and CM1 was obtained from Novacastra Laboratories Ltd (Newcastle upon Tyne, UK). Rabbit anti-human polyclonal antibody, DH1, reacts with involucrin, the major protein precursor of the corni®ed envelope, and was the generous gift of Dr Watt, Imperial Cancer Research Fund (Dover and Watt, 1987) . Secondary antibodies and conjugates including rabbit anti-mouse, horseradish peroxidase-conjugated swine anti-rabbit, biotinylated rabbit anti-mouse, biotinylated swine anti-rabbit and¯uorescein-conjugated goat anti-rabbit (GAR-FITC) antibodies were obtained from Dako Ltd.
Immunoblotting
Single cell suspensions prepared from epithelial cell cultures were washed twice with ice-cold phosphate buered saline (PBS), the cells pelleted, then resuspended in sample buer (2% w/v SDS, 80 mM Tris-HCl, pH 6.8, 0.35 M b-mercaptoethanol, 10% v/v glycerol, 0.025% w/v bromophenol blue) such that 40 ml contained 10 6 cells. Samples were sonicated for 30 s to shear genomic DNA, boiled for 5 min and microfuged at high speed for 5 min to clarify ± any pellets formed were discarded.
Samples were resolved by electrophoresis through a 7.5% Tris/glycine SDS-polyacrylamide gel; 40 ml samples were loaded into the wells of the gel and separated by electrophoresis at 100 V through the stacking gel and 200 V through the separating gel. The proteins were subsequently electrotransferred to 0.45 mM nitrocellulose.
LMP was detected on blots using an indirect triple-layer system. Blots were ®rst blocked with PBS, 0.05% Tween 20, 5% w/v nonfat dry milk for 3 h at room temperature, then incubated with supernatant containing anti-LMP antibody, S12, diluted 1 : 10, overnight at 48C. Blots were washed with four changes of PBS, 0.05% Tween 20 over a period of 1 h at room temperature, then incubated with rabbit anti-mouse antibody, diluted 1 : 1000, for 40 min ± 1 h at room temperature. Blots were washed and ®nally incubated with horseradish peroxidase-conjugated swine anti-rabbit antibody, diluted 1 : 10 000, for 30 min at room temperature. All antibodies were diluted in PBS, 0.05% Tween 20, 5% w/v nonfat dry milk. Blots were then washed and proteins visualised by chemiluminescence (ECL Western blotting detection kit, Amersham International plc, Little Chalfont, UK) followed by exposure to autoradiography ®lm (Hyper®lm-MP, Amersham International plc).
Tumorigenicity testing
Three stable transfectants of the HaCaT (HLMP1,2,3) and SCC12F (SLMP1,2,3) lines were tested for tumorigenicity in SCID mice (kindly provided by Dr Bancroft, London School of Hygiene and Tropical Medicine). Two control transfectants of each epithelial cell line (Hneo1,2; Sneo1,2) were also tested. For each line, 10 7 cells in 100 ml injectable saline were injected subcutaneously into the¯anks of 4 ± 6 10 week old female mice. The mice were checked daily for tumours, and any tumours that developed were measured weekly using calipers. If a tumour did not develop at a site within 8 weeks following injection, that site was scored negative. A cell line that produced a tumour at any of the injected sites was considered tumorigenic. At the end point of the experiment the mice were killed by cervical dislocation and any tumours plus organs including lungs, liver and spleen were taken for histological and immunohistochemical examination.
Histology and immunohistochemistry
Tumours and organs were ®xed in 10% formal saline, processed, embedded in paran wax, then sectioned (4 mm) and stained with haematoxylin and eosin for histological examination. Deparanized and rehydrated tumour sections were also stained with various antibodies using a streptavidin-biotin complex immunoperoxidase protocol. Immunoproducts were visualised by the application of diaminobenzidine tetrahydrochloride, and sections lightly counterstained with Mayer's haemalum.
Induction of epithelial terminal dierentiation
HaCaT and SCC12F cells were induced to undergo terminal dierentiation by suspension in culture medium made viscous by the addition of methyl-cellulose (4000 centipoises; Aldrich Chemical Co, Gillingham, UK) to a ®nal concentration of 1.44% (Green, 1977) . Cells were seeded at 10 5 cells per ml methyl-cellulose medium into bacteriological Petri dishes coated with polyHEMA (Aldrich Chemical Co) to inhibit cell adhesion (Folkman and Moscona, 1978) , and incubated at 378C in a fully humidi®ed 5% CO 2 atmosphere. At various times, cells were harvested by diluting the methyl-cellulose with PBS and recovering the cells by centrifugation. Aliquots of cells were stained by indirect immuno¯uorescence with antibody to involucrin, and percent involucrin positive cells determined from photographs; at least 200 cells per sample were counted. Further aliquots of cells were taken for analysis of LMP expression by immunoblotting.
Indirect immuno¯uorescence
Epithelial cell suspensions were dried onto coverslips and the presence of involucrin protein visualised by indirect immuno¯uorescence. Cells were ®xed with 3.7% formaldehyde in PBS for 10 min at room temperature and subsequently permeabilised with absolute methanol for 5 min on ice. Cells were incubated with anti-involucrin antibody, DH1, diluted 1 : 250 in PBS, for 1 h at room temperature, washed extensively in PBS, then incubated with GAR-FITC, diluted 1 : 50 in PBS, for 45 min at room temperature. The cells were washed in PBS, mounted (90% glycerol in PBS) and examined using a Zeiss Axioplan microscope.
Statistics
The Mann-Whitney test was used to determine any signi®cant dierence between fold increases in percent involucrin positive cells observed following culture in suspension of control lines (parental and pSV2-neo transfectants) and those observed following suspension culture of LMP expressing transfectants.
